During the last session, Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)’s traded shares were 1.19 million, with the beta value of the company hitting 0.68. At the end of the trading day, the stock’s price was $0.27, reflecting an intraday loss of -9.40% or -$0.03. The 52-week high for the GLMD share is $0.90, that puts it down -233.33 from that peak though still a striking 3.7% gain since the share price plummeted to a 52-week low of $0.26. The company’s market capitalization is $1.61M, and the average intraday trading volume over the past 10 days was 2.15 million shares, and the average trade volume was 359.76K shares over the past three months.
Galmed Pharmaceuticals Ltd (GLMD) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. GLMD has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) trade information
Galmed Pharmaceuticals Ltd (GLMD) registered a -9.40% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -9.40% in intraday trading to $0.27, hitting a weekly high. The stock’s 5-day price performance is -37.67%, and it has moved by -13.21% in 30 days. Based on these gigs, the overall price performance for the year is -66.91%. The short interest in Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) is 12057.0 shares and it means that shorts have 0.36 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 21.08%.
GLMD Dividends
Galmed Pharmaceuticals Ltd is due to release its next quarterly earnings in September. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
